These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7491428)

  • 21. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
    Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
    Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
    Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005.
    Soto-Salgado M; Pérez CM; Burgos-Calderón R; Torres EA; Suárez E
    P R Health Sci J; 2009 Mar; 28(1):18-23. PubMed ID: 19266735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
    Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus infection in hospitalized children.
    Tyczyńska-Hoffmann B; Szklarska-Szczepanik A; Swincow G; Adamska I; Michalska K; Łoś E; Czerwionka-Szaflarska M
    Med Sci Monit; 2000; 6(2):361-4. PubMed ID: 11208338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study.
    Cadranel JF; Di Martino V; Lambrey G; Mourlhon C; Nalet B; Anciaux ML; Richard C; Bigué JP; Barjon JN; Bories C; Barbare JC; Halimi C; Ribière O; Eugène C; Pauwels A; Jeanne S; Donato L; Dumouchel P; Pariente A; Duverlie G; Devergie B; Arlot S; Capron D
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):829-36. PubMed ID: 18794595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
    Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
    Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).
    Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R
    Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk.
    Daw MA; Elkaber MA; Drah AM; Werfalli MM; Mihat AA; Siala IM
    Saudi Med J; 2002 Nov; 23(11):1356-60. PubMed ID: 12506296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of anti-HCV antibodies among adults in Poland--results of cross-sectional study in general population].
    Godzik P; Kołakowska A; Madaliński K; Stepień M; Zieliński A; Góralewska A; Kazimierska M; Kunc-Kozioł R; Nadolska B; Pawłowska A; Piskorek A; Równiak J; Rosińska M
    Przegl Epidemiol; 2012; 66(4):575-80. PubMed ID: 23484383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis C in health care workers investigated by 2nd generation enzyme-linked and line immunoassays.
    Frider B; Sookoian S; Castaño G; Rébora N; Gutfraind Z; Mirta K; Veyretou F; Wainstein C
    Acta Gastroenterol Latinoam; 1994; 24(2):71-5. PubMed ID: 7817696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of anti-HCV among HIV-infected persons and general population.
    Suwanagool S; Tieangrim S; Ratanasuwan W; Mekanantagosol S; Luengrojanakul P; Kunasol P
    J Med Assoc Thai; 1995 Nov; 78(11):611-7. PubMed ID: 8576673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and basic determinants of hepatitis C antibodies in medical students in Katowice, Poland.
    Braczkowska B; Kowalskan M; Zejda JE; Beniowski M; Kulawik I; Kuleszyński J; Jagodziński L
    Przegl Lek; 2006; 63(7):539-42. PubMed ID: 17203804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of hepatitis C virus infection among surgical nurses, their patients and blood donation candidates in Poland.
    Ganczak M; Korzeń M; Szych Z
    J Hosp Infect; 2012 Dec; 82(4):266-70. PubMed ID: 23110996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.